Pharmacologic Treatment of Pediatric Insomnia

Child and Adolescent Psychiatric Clinics of North America

Volumn 18, Issue 4, 2009, Pages 1001-1016

  Owens, Judith A ^a   Moturi, Sricharan ^b  

^a BROWN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Children; Hypnotics; Insomnia; Psychopharmacology; Treatment

Indexed keywords

AGOMELATINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CHAMOMILE; CHLORAL HYDRATE; CITALOPRAM; CLONAZEPAM; CLONIDINE; DIPHENHYDRAMINE; DOXEPIN; ESZOPICLONE; FLUOXETINE; FLUVOXAMINE; GUANFACINE; HYDROXYZINE; HYDROXYZINE EMBONATE; HYPNOTIC SEDATIVE AGENT; MELATONIN; NEFAZODONE; PAROXETINE; PLACEBO; RAMELTEON; SEROTONIN UPTAKE INHIBITOR; TASIMELTEON; TRAZODONE; TRIMIPRAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALERIAN; ZALEPLON; ZOLPIDEM TARTRATE;

ADOLESCENT; AGGRESSION; ALCOHOL CONSUMPTION; ANTEROGRADE AMNESIA; ANTICHOLINERGIC SYNDROME; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BEDTIME DOSAGE; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CAREGIVER BURDEN; CHILD; CHILD HEALTH CARE; CHRONOTHERAPY; CLINICAL PRACTICE; COGNITIVE DEFECT; COMORBIDITY; CONSENSUS DEVELOPMENT; CONVULSION; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE ASSOCIATION; DIZZINESS; DROWSINESS; DRUG ABUSE; DRUG DOSE TITRATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG OVERDOSE; DRUG SAFETY; DYSPHORIA; EMOTIONAL DISORDER; HERBAL MEDICINE; HUMAN; HYPERTENSION; HYPOTENSION; IMPULSIVENESS; INSOMNIA; IRRITABILITY; LIVER DYSFUNCTION; MAJOR DEPRESSION; MEDICAL DECISION MAKING; MEDICAL EXPERT; MENTAL DISEASE; NEUROLOGIC DISEASE; OFF LABEL DRUG USE; PARASOMNIA; PARENTAL BEHAVIOR; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; RESPIRATION DEPRESSION; RESTLESS LEGS SYNDROME; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP TIME; TINNITUS; TREATMENT DURATION; URINE RETENTION; WEIGHT GAIN; XEROSTOMIA;

ADOLESCENT; ADRENERGIC ALPHA-AGONISTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BEHAVIOR THERAPY; CHILD; COMORBIDITY; EVIDENCE-BASED MEDICINE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPNOTICS AND SEDATIVES; MELATONIN; PATIENT CARE TEAM; PLANT PREPARATIONS; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 70349856155     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chc.2009.04.009     Document Type: Review

References (83)

1. American Academy of Sleep Medicine. The international classification of sleep disorders. 2nd edition (2005), American Academy of Sleep Medicine, Westchester
2. Sadeh A., Raviv A., and Gruber R. Sleep patterns and sleep disruptions in school-age children. Dev Psychol 36 3 (2000) 291-301
3. Johnson E.O., Roth T., Schultz L., et al. Epidemiology of DSM-IV insomnia in adolescence: lifetime prevalence, chronicity, and an emergent gender difference. Pediatrics 117 2 (2006) e247-e256
4. Quine L. Sleep problems in primary school children: comparison between mainstream and special school children. Child Care Health Dev 27 3 (2001) 201-221
5. Stores G. Sleep-wake function in children with neurodevelopmental and psychiatric disorders. Semin Pediatr Neurol 8 4 (2001) 188-197
6. Roberts R.E., Roberts C.R., and Duong H.T. Chronic insomnia and its negative consequences for health and functioning of adolescents: a 12-month prospective study. J Adolesc Health 42 3 (2008) 294-302 [Epub 2007 Dec 21]
7. Cortese S., Konofal E., Yateman N., et al. Sleep and alertness in children with attention-deficit/hyperactivity disorder: a systematic review of literature. Sleep 29 4 (2006) 504-511
8. Cortese S., Konofal E., Lecendreux M., et al. Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep 28 8 (2005) 1007-1013
9. Wiggs L., and Stores G. Behavioural treatment for sleep problems in children with severe intellectual disabilities and daytime challenging behaviour: effect on mothers and fathers. Br J Health Psychol 6 Pt 3 (2001) 257-269
10. Mindell J.A., Kuhn B., Lewin D.S., et al. Behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep 29 10 (2006) 1263-1276
11. Mindell J.A., Emslie G., Blumer J., et al. Pharmacologic management of insomnia in children and adolescents: consensus statement. Pediatrics 117 6 (2006) e1223-e1232
12. Owens J.A., Babcock D., Blumer J., et al. The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. A consensus meeting summary. J Clin Sleep Med 1 1 (2005) 49-59
13. Zito J.M., Safer D.J., DosReis S., et al. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med 157 1 (2003) 17-25
14. Owens J.A., Rosen C.L., and Mindell J.A. Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians. Pediatrics 111 5 Pt 1 (2003) e628-e635
15. Meltzer L.J., Mindell J.A., Owens J.A., et al. Use of sleep medications in hospitalized pediatric patients. Pediatrics 119 6 (2007) 1047-1055
16. Stojanovski S.D., Rasu R.S., Balkrishnan R., et al. Trends in medication prescribing for pediatric sleep difficulties in US outpatient settings. Sleep 30 8 (2007) 1013-1017
17. Owens J.A., and Dalzell V. Use of the 'BEARS' sleep screening tool in a pediatric residents' continuity clinic: a pilot study. Sleep Med 6 1 (2005) 63-69 [Epub 2005 Jan 12]
18. Mindell J.A. Empirically supported treatments in pediatric psychology: bedtime refusal and night wakings in young children. J Pediatr Psychol 24 6 (1999) 465-481
19. Kuhn B.R., and Elliott A.J. Treatment efficacy in behavioral pediatric sleep medicine. J Psychosom Res 54 6 (2003) 587-597
20. Pelayo R., and Dubik M. Pediatric sleep pharmacology. Semin Pediatr Neurol 15 2 (2008) 79-90
21. Sadeh A., Horowitz I., Wolach-Benodis L., et al. Sleep and pulmonary function in children with well-controlled, stable asthma. Sleep 21 4 (1998) 379-384
22. Dahl R.E., Bernhisel-Broadbent J., Scanlon-Holdford S., et al. Sleep disturbances in children with atopic dermatitis. Arch Pediatr Adolesc Med 149 8 (1995) 856-860
23. Amin R., Bean J., Burklow K., et al. The relationship between sleep disturbance and pulmonary function in stable pediatric cystic fibrosis patients. Chest 128 3 (2005) 1357-1363
24. Lewin D.S., and Dahl R.E. Importance of sleep in the management of pediatric pain. J Dev Behav Pediatr 20 4 (1999) 244-252
25. Bloom B.J., Owens J.A., McGuinn M., et al. Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis. J Rheumatol 29 1 (2002) 169-173
26. Hysing M., Sivertsen B., Stormark K.M., et al. Sleep in children with chronic illness, and the relation to emotional and behavioral problems: a population-based study. J Pediatr Psychol 34 6 (2009) 665-670
27. Ivanenko A., Crabtree V.M., Obrien L.M., et al. Sleep complaints and psychiatric symptoms in children evaluated at a pediatric mental health clinic. J Clin Sleep Med 2 1 (2006) 42-48
28. Kallepalli B.R., Bhatara V.S., Fogas B.S., et al. Trazodone is only slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders. J Child Adolesc Psychopharmacol 7 2 (1997) 97-107
29. Richdale A.L. Sleep problems in autism: prevalence, cause, and intervention. Dev Med Child Neurol 41 1 (1999) 60-66
30. Schnoes C.J., Kuhn B.R., Workman E.F., et al. Pediatric prescribing practices for clonidine and other pharmacologic agents for children with sleep disturbance. Clin Pediatr (Phila) 45 3 (2006) 229-238
31. Prince J.B., Wilens T.E., Biederman J., et al. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry 35 5 (1996) 599-605
32. Palumbo D.R., Sallee F.R., Pelham Jr. W.E., et al. Clonidine for attention-deficit/hyperactivity disorder. I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry 47 2 (2008) 180-188
33. Daviss W.B., Patel N.C., Robb A.S., et al. Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. J Am Acad Child Adolesc Psychiatry 47 2 (2008) 189-198
34. Ingrassia A., and Turk J. The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders: a case series. Eur Child Adolesc Psychiatry 14 1 (2005) 34-40
35. Arnsten A.F., Scahill L., and Findling R.L. Alpha2-adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. J Child Adolesc Psychopharmacol 17 4 (2007) 393-406
36. Szot P., Lester M., Laughlin M.L., et al. The anticonvulsant and proconvulsant effects of alpha2-adrenoreceptor agonists are mediated by distinct populations of alpha2A-adrenoreceptors. Neuroscience 126 3 (2004) 795-803
37. Biederman J., Melmed R.D., Patel A., et al. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics 121 1 (2008) e73-e84
38. Pandi-Perumal S.R., Srinivasan V., Spence D.W., et al. Role of the melatonin system in the control of sleep: therapeutic implications. CNS Drugs 21 12 (2007) 995-1018
39. Zhdanova I.V., Wurtman R.J., Lynch H.J., et al. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 57 5 (1995) 552-558
40. Cavallo A., and Ritschel W.A. Pharmacokinetics of melatonin in human sexual maturation. J Clin Endocrinol Metab 81 5 (1996) 1882-1886
41. O'Callaghan F.J., Clarke A.A., Hancock E., et al. Use of melatonin to treat sleep disorders in tuberous sclerosis. Dev Med Child Neurol 41 2 (1999) 123-126
42. De Leersnyder H., Bresson J.L., de Blois M.C., et al. Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome. J Med Genet 40 1 (2003) 74-78
43. McArthur A.J., and Budden S.S. Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Dev Med Child Neurol 40 3 (1998) 186-192
44. Braam W., Didden R., Smits M.G., et al. Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial. J Child Neurol 23 6 (2008) 649-654
45. Sack R.L., Brandes R.W., Kendall A.R., et al. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 343 15 (2000) 1070-1077
46. Ivanenko A., Crabtree V.M., Tauman R., et al. Melatonin in children and adolescents with insomnia: a retrospective study. Clin Pediatr (Phila) 42 1 (2003) 51-58
47. Van der Heijden K.B., Smits M.G., Van Someren E.J., et al. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry 46 2 (2007) 233-241
48. Weiss M.D., Wasdell M.B., Bomben M.M., et al. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry 45 5 (2006) 512-519
49. Giannotti F., Cortesi F., Cerquiglini A., et al. An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. J Autism Dev Disord 36 6 (2006) 741-752
50. Andersen I.M., Kaczmarska J., McGrew S.G., et al. Melatonin for insomnia in children with autism spectrum disorders. J Child Neurol 23 5 (2008) 482-485
51. Paavonen E.J., Nieminen-von Wendt T., Vanhala R., et al. Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder. J Child Adolesc Psychopharmacol 13 1 (2003) 83-95
52. Buscemi N., Vandermeer B., Hooton N., et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ 332 7538 (2006) 385-393
53. Sajith S.G., and Clarke D. Melatonin and sleep disorders associated with intellectual disability: a clinical review. J Intellect Disabil Res 51 Pt 1 (2007) 2-13
54. Luboshitzky R., Lavi S., Thuma I., et al. Increased nocturnal melatonin secretion in male patients with hypogonadotropic hypogonadism and delayed puberty. J Clin Endocrinol Metab 80 7 (1995) 2144-2148
55. Sheldon S.H. Pro-convulsant effects of oral melatonin in neurologically disabled children. [letter]. Lancet 351 9111 (1998) 1254
56. Jan J.E., Espezel H., and Appleton R.E. The treatment of sleep disorders with melatonin. Dev Med Child Neurol 36 2 (1994) 97-107
57. Sutherland E.R., Martin R.J., Ellison M.C., et al. Immunomodulatory effects of melatonin in asthma. Am J Respir Crit Care Med 166 8 (2002) 1055-1061
58. Szeinberg A., Borodkin K., and Dagan Y. Melatonin treatment in adolescents with delayed sleep phase syndrome. Clin Pediatr (Phila) 45 9 (2006) 809-818
59. Stigler K.A., Posey D.J., and McDougle C.J. Ramelteon for insomnia in two youths with autistic disorder. J Child Adolesc Psychopharmacol 16 5 (2006) 631-636
60. Merenstein D., Diener-West M., Halbower A.C., et al. The trial of infant response to diphenhydramine: the TIRED study-a randomized, controlled, patient-oriented trial. Arch Pediatr Adolesc Med 160 7 (2006) 707-712
61. Richardson G.S., Roehrs T.A., Rosenthal L., et al. Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol 22 5 (2002) 511-515
62. Bender B.G., McCormick D.R., and Milgrom H. Children's school performance is not impaired by short-term administration of diphenhydramine or loratadine. J Pediatr 138 5 (2001) 656-660
63. Baker A.M., Johnson D.G., Levisky J.A., et al. Fatal diphenhydramine intoxication in infants. J Forensic Sci 48 2 (2003) 425-428
64. Pershad J., Palmisano P., and Nichols M. Chloral hydrate: the good and the bad. Pediatr Emerg Care 15 6 (1999) 432-435
65. Möhler H., Fritschy J.M., and Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther 300 1 (2002) 2-8
66. Zammit G.K., Corser B., Doghramji K., et al. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening. J Clin Sleep Med 2 4 (2006) 417-423
67. Walsh J.K., Krystal A.D., Amato D.A., et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep 30 8 (2007) 959-968
68. Liskow B., and Pikalov A. Zaleplon overdose associated with sleepwalking and complex behavior. J Am Acad Child Adolesc Psychiatry 43 8 (2004) 927-928
69. Sein Anand J., Chodorowski Z., and Hajduk A. [Acute intoxication with zaleplon: a case report]. Przegl Lek 64 4-5 (2007) 310-311 [Polish]
70. Kurta D.L., Myers L.B., and Krenzelok E.P. Zolpidem (Ambien): a pediatric case series. J Toxicol Clin Toxicol 35 5 (1997) 453-457
71. Hajak G., Rodenbeck A., Voderholzer U., et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 62 6 (2001) 453-463
72. Riemann D., Voderholzer U., Cohrs S., et al. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry 35 5 (2002) 165-174
73. Walsh J.K., Erman M., Erwin C.W., et al. Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia. Hum Psychopharmacol 13 (1998) 191-198
74. Wiegand M.H., Galanakis P., and Schreiner R. Nefazodone in primary insomnia: an open pilot study. Prog Neuropsychopharmacol Biol Psychiatry 28 7 (2004) 1071-1078
75. Nowell P.D., Reynolds III C.F., Buysse D.J., et al. Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data. J Clin Psychiatry 60 2 (1999) 89-95
76. Sharpley A.L., Bhagwagar Z., Hafizi S., et al. Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients. J Clin Psychiatry 64 2 (2003) 192-196
77. Keshavan M.S., Prasad K.M., Montrose D.M., et al. Sleep quality and architecture in quetiapine, risperidone, or never-treated schizophrenia patients. J Clin Psychopharmacol 27 6 (2007) 703-705
78. Bourgeois B. The relationship between sleep and epilepsy in children. Semin Pediatr Neurol 3 1 (1996) 29-35
79. Kotagal S. Sleep in children at risk. Sleep Med Clin 2 3 (2007) 477-490
80. Capone G.T., Goyal P., Grados M., et al. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study. J Dev Behav Pediatr 29 2 (2008) 106-116
81. Ziegler G., Ploch M., Miettinen-Baumann A., et al. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia: a randomized, double-blind, comparative clinical study. Eur J Med Res 7 11 (2002) 480-486
82. Meolie A.L., Rosen C., Kristo D., et al. Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence. J Clin Sleep Med 1 2 (2005) 173-187
83. Gardiner P., and Kemper K.J. Insomnia: herbal and dietary alternatives to counting sheep. Contemp Pediatr 19 2 (2002) 69-87